RE: Update21 Dec 2022 10:23
Re my remarks from July/August this year:
PARTIAL EXTRACT.... "As part of the purchase agreement with the previous owners of Itaconix Corporation, a contingent ... deferred performance related consideration will be payable to the Itaconix Corporation shareholders, subject to the achievement of certain growth targets ... based on 50% of incremental annual net sales value ... in excess of the prior year...
The deferred performance related consideration is capped at $6m in aggregate. Such deferred performance consideration, if any, will be satisfied annually entirely in ordinary shares of Itaconix plc "
Seems that performance was linked primarily to volume rather than income or even profit (depending on definition of 'certain growth targets'), but as the consideration is paid in shares, you would hope that the beneficiaries' interest is best served by keeping a decent margin on sales.
Even if there is a payment of full amount available for this (final) year of the scheme, you would think that there would be an issuance of only a small percentage of new shares, and predominantly to individuals who have a vested interest in seeing the company continue on a path to profitability.